NCT02532907View on ClinicalTrials.gov

Study of Hepatic Responses in Patients Receiving Direct-acting Anti-HCV Drugs

CompletedOBSERVATIONAL
Enrollment

5

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

July 10, 2018

Study Completion Date

July 10, 2018

Conditions
Hepatitis C
Interventions
PROCEDURE

Liver Biopsy

patients will get a research liver biopsy pre-DAA treatment and either 4 or the standard 12 week time point. The liver biopsy is performed using standard protocol with ultrasound guidance.

Trial Locations (1)

80045

Sandra Boimbo, Aurora

All Listed Sponsors
lead

University of Colorado, Denver

OTHER

NCT02532907 - Study of Hepatic Responses in Patients Receiving Direct-acting Anti-HCV Drugs | Biotech Hunter | Biotech Hunter